A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma
Francesca I. Ezughah, Robert S. Dawe, Sally H. Ibbotson, Colin J. Fleming
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma'. Together they form a unique fingerprint.